Archive - January 2021
Diurnal seeks marketing authorisation for Chronocort in the UK
Eli Lilly announces mid-stage trial success for donanemab in Alzheimer’s
Synairgen begins large-scale trial of inhaled COVID-19 treatment
FDA Approves First Generic for Glucagon
Hunting for Link Between Video Games and Children’s Obesity
AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
BioNTech boosts COVID-19 vaccine capacity and aims to deliver 2 billion doses in 2021
Lilly’s anti-amyloid antibody donanemab renews Alzheimer’s hopes